Vikas Lifecare Limited has informed the Exchange about General Updates
VIKASLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On April 16, 2025, officials from the Enforcement Directorate (ED) visited Vikas Lifecare's office and the residence of its promoter as part of an investigation involving a third-party and related transactions. The company says it fully cooperated and provided all documents and clarifications sought during the visit. The visit concluded the same day with no adverse findings or observations reported. The company has stated there is no material impact on its financials, operations, or other activities. The intimation was filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations.
While the ED visit itself may cause short-term investor concern and possible volatility in the stock, the company has clarified the probe relates to a third party and resulted in no adverse findings, suggesting limited long-term damage. Shareholders should monitor for any further developments in this matter.